presseportal.de : Avastin Plus Commonly Used Chemotherapies Improve...
Geschrieben von rootam 30.05.2009 02:38:30 (38 x gelesen)
Roche Pharmaceuticals: Basel, Switzerland (ots/PRNewswire) - - RIBBON-1 Study Confirms Benefit of Avastin in Treating HER2-Negative Breast Cancer - For Non-US, Non-UK and Non-Austrian Media Results from the phase III RIBBON-1 study presented ...
